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Decisions about typhoid fever prevention and control are based on estimates
of typhoid incidence and their uncertainty. Lack of specific clinical diagnostic
criteria, poorly sensitive diagnostic tests, and scarcity of accurate and complete
datasets contribute to difficulties in calculating age-specific population-level
typhoid incidence. Using data from the Strategic Typhoid Alliance across Africa
and Asia program, we integrated demographic censuses, healthcare utilization
surveys, facility-based surveillance, and serological surveillance from Malawi,
Nepal, and Bangladesh to account for under-detection of cases. We developed
a Bayesian approach that adjusts the count of reported blood-culture-positive
cases for blood culture detection, blood culture collection, and healthcare
seeking—and how these factors vary by age—while combining information
from prior published studies. We validated the model using simulated data.
The ratio of observed to adjusted incidence rates was 7.7 (95% credible inter-
val [CrI]: 6.0-12.4) in Malawi, 14.4 (95% CrI: 9.3-24.9) in Nepal, and 7.0 (95%
CrI: 5.6-9.2) in Bangladesh. The probability of blood culture collection led to the
largest adjustment in Malawi, while the probability of seeking healthcare con-
tributed the most in Nepal and Bangladesh; adjustment factors varied by age.
Adjusted incidence rates were within or below the seroincidence rate limits of
typhoid infection. Estimates of blood-culture-confirmed typhoid fever without
these adjustments results in considerable underestimation of the true incidence
of typhoid fever. Our approach allows each phase of the reporting process to
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be synthesized to estimate the adjusted incidence of typhoid fever while cor-
rectly characterizing uncertainty, which can inform decision-making for typhoid
prevention and control.
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1 BACKGROUND
Current estimates of typhoid fever incidence serve as a basis for decision-making around typhoid control. However,
facility-based cases of blood-culture-confirmed typhoid fever are considerably lower than the true number of those with
the disease1 because the reported numbers do not account for individuals with typhoid fever who do not seek healthcare,
fail to receive a diagnostic test, or falsely test negative for typhoid (Figure 1). Annually, typhoid fever is estimated to cause
11 to 18 million infections and 100 000 to 200 000 deaths,2-4 but there is considerable uncertainty in these estimates.
Studies suggest that somewhere between 60% and 90% individuals with typhoid fever do not receive adequate medical
attention, in part because they do not to seek formal treatment.5,6 Previous studies have found that healthcare utilization is
correlated with the number of household members, distance to the healthcare facility, financial affordability, and trust in
formal healthcare.7,8 Furthermore, typhoid fever is often misdiagnosed based on physical examinations alone.1 Inconsis-
tent clinical diagnoses arise because symptoms of typhoid, particularly prolonged fever, are also the main characteristics
of other common infectious diseases in typhoid endemic settings.1,9 Even if a blood culture test is recommended and lab-
oratory facilities are available, not all patients will consent. Diagnostic tests can be invasive, and parents or guardians of
young children sometimes do not want their children to have large amounts of blood drawn when they are already ill.
In resource-poor countries in particular, lack of supplies and personnel lead to long wait times for receiving healthcare,
further adding to lower rates of confirmatory testing. Clinical opinion on the cause of fever can also affect the likelihood
of blood being drawn for culture.10
Suboptimal diagnostic tests further contribute to underestimation of cases. Blood culture collection is the mainstay
diagnostic test for typhoid fever,11 but it fails to capture approximately half of the true cases. The test sensitivity depends
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F I G U R E 1 Flowchart of typhoid disease and observation process, and adjustment method to estimate the true number of cases. The
pyramid (left) illustrates the different steps in the observation process for reporting typhoid incidence, with details on how parameters are
estimated at each step. The flowchart (right) illustrates the corresponding Bayesian framework for each step of the observation process and
which datasets and variables are used for adjustment. Adjustments for blood culture sensitivity are shown in purple, the probability of
receiving a blood culture test is shown in red, and the probability of seeking healthcare is shown in blue. Variable definitions: 𝜆, typhoid
incidence rate; 𝜙, a probability estimated in the model; S, sensitivity of blood culture; B, blood culture collection; H, healthcare seeking; a,
age category; c, site. Abbreviation: BC, blood culture [Colour figure can be viewed at wileyonlinelibrary.com]
on the volume of blood drawn and whether a patient has recently received antibiotics.12 Thus, even if an individual with
typhoid receives a blood culture test, he or she may falsely test negative and not be included in the reported number of
confirmed cases.
The true incidence of typhoid fever cannot be directly assessed but can be estimated by accounting for steps in
the reporting process. Methods to combine data from several sources to adjust for underestimation while accurately
quantifying the uncertainty have been previously applied to estimate the incidence of HIV and influenza.13-17 Bayesian
methods are conducive to integrating multiple data sources in this way. In this work, we developed a Bayesian multiplier
framework to estimate population-based incidence of typhoid fever based on data collected from study sites in Africa
and Asia.
2 METHODS
2.1 Study design and data
We developed a framework within the Bayesian setting to integrate data from multiple sources to estimate the
population-based incidence of typhoid fever based on passive surveillance in Malawi, Nepal, and Bangladesh, three
typhoid-endemic countries with different demographics, healthcare systems, and access to diagnostics.18 Using this
model, we sought to estimate the adjustment factors needed to calculate the “true” incidence of typhoid fever occurring
in the population under surveillance, and to examine how these values varied by age across the three study sites, by com-
bining information collected from the study population with estimates from prior published studies. We also compared
our final estimates to serosurveillance data collected from the same population catchment areas.
Data came from the Strategic Typhoid Alliance across Africa and Asia (STRATAA) program, a prospective observa-
tional, population-based epidemiological study of typhoid incidence, transmission, and antibiotic resistance. From 2016 to
2018, the STRATAA investigators conducted demographic censuses, healthcare utilization surveys (HUS), passive surveil-
lance, and serosurveys at each of three sites (Blantyre, Malawi; Kathmandu, Nepal; and Dhaka, Bangladesh). STRATAA’s
study design and methods have been detailed elsewhere,18 and are briefly described below.
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2.1.1 Demographic census data
The demographic census was used to estimate the overall person-time contribution for incidence rate calculations. The
survey documented household locations and individual characteristics for each geographically demarcated study area.
The census provided information on each individual’s birthdate, sex, position in the household, marital status (if appli-
cable), education level, and employment status (if applicable). Participants were surveyed and consented as households.
Approximately 100 000 individuals were enrolled at each site, and census updates were carried out one to three times
depending on the site. Over the 2-year study period, this population amounted to 200 018 person-years of observation
(pyo) in Malawi, 203 444 in Nepal, and 222 636 in Bangladesh.
2.1.2 Passive surveillance
Clinical cases of culture-confirmed typhoid fever were identified through passive surveillance. Individuals living in the
study areas who presented at partner facilities with a documented temperature of ≥38.0◦C or a history of fever lasting
at least 2 days upon presentation were eligible for enrollment. Healthcare workers collected clinical and demographic
information from enrolled febrile individuals, as well as microbiological samples (urine, feces, and blood).
2.1.3 Healthcare utilization survey
To estimate the proportion of cases captured by study facilities, we collected data from the head of household regarding
actual and hypothetical usage of healthcare facilities for febrile episodes among household members from each of three
age groups (<5 years, 5-14 years, >14 years), if available. Approximately 735 households were randomly chosen at each
site, with the requirement that all households have at least one child (14 years or younger). The HUS contained questions
regarding household and individual health behavior; house and household characteristics; water, sanitation and hygiene
practices; and healthcare utilization (actual and hypothetical).
2.1.4 Serosurveillance
Serosurveys were conducted in the census population to assess the underlying rate of seroconversion to typhoid, and to
identify potential chronic carriers, initially based on anti-Vi immunoglobulin G (IgG). Approximately 8500 participants
from each site were randomly selected in an age-stratified manner. Healthcare workers collected serum samples from
each individual upon enrollment and again 3 months later. Seroconversion was defined as a ≥2-fold rise in anti-Vi IgG
titre between the first and second sample drawn and an absolute titre ≥50 EU/mL at the second time point to account for
small variations above the lower limit of detection for the assay. We estimated the seroincidence by dividing the number
of seroconversions by the person-time contribution between serum samples in each age group; 95% binomial confidence
intervals (CI) were estimated.
2.2 Approach and data analysis
We adjusted the reported number of blood-culture-positive cases of typhoid fever for each of the three phases of the
reporting process: blood culture detection, blood culture collection, and healthcare seeking. We used information on
healthcare seeking for fever and the proportion of fever cases who were enrolled and had blood taken for culture and
combined this information with published data on risk factors for typhoid fever to reach our final adjusted numbers.
We then examined whether our adjusted estimates were within the maximum range expected based on seroincidence
estimates, which capture all clinical and sub-clinical cases.
The estimation of typhoid fever incidence is complicated by the relationship between fever and typhoid fever.
In each phase of the reporting process, we can observe whether a person has a fever, but not necessarily whether
he/she has typhoid fever. Thus, the symptomatic typhoid fever pyramid is nested within a larger fever pyramid
(Figure S1).
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where 𝜆observed,a,c is the observed incidence rate of typhoid fever, adjusted for pyo from the demographic census
(person_timea,c) (Figure 1, Table 1). Subscript a represents age category, where
a =
⎧⎪⎪⎪⎨⎪⎪⎪⎩
1 for children < 5 years old,
2 for children 5 to 9 years old,
3 for children 10 to 14 years old,
4 for individuals 15 to 29 years old,
5 for individuals ≥ 30 years old,






The incidence rate of reported cases can be rewritten as the product of the healthcare-seeking typhoid incidence rate
and the probability of a case being captured at each of the three steps of the reporting process,
𝜆observed,a,c = 𝜆adjusted,a,c ∗ 𝜙Sa,c ∗ 𝜙Ba,c ∗ 𝜙Ha,c, (2)
where 𝜆adjusted,a,c is the final adjusted incidence of typhoid fever incidence, 𝜙Sa,c is blood culture sensitivity, 𝜙Ba,c is the
probability of receiving a blood culture test, and 𝜙Ha,c is the probability of seeking healthcare for typhoid fever. Superscript
S denotes that the parameter refers to the blood culture detection (ie, sensitivity) phase of reporting, superscript B denotes
that the parameter is referring to the blood culture collection (ie, testing) phase of reporting, and superscript H denotes
that the parameter is referring to the healthcare-seeking phase of reporting.
All model input parameters, with their prior distributions and corresponding data sources, are listed in Table 1. The
three steps in the adjustment process (blood culture detection, blood culture collection, and healthcare seeking), are
detailed below.
2.2.1 Adjustment for blood culture sensitivity (𝜙Sa,c)
For each individual who received a blood culture test, we inferred whether or not they were a “true” typhoid fever case
by adjusting for the specificity and sensitivity of blood culture for typhoid diagnosis (Table S1). First, we assumed that the
specificity of blood culture is 100%; thus, all individuals who tested positive for typhoid were assumed to be true cases of
the disease. Second, we assumed that among those who tested negative, the probability of being an actual typhoid fever
case depended on the volume of blood drawn and prior antimicrobial use, both of which were recorded in the passive
surveillance data. Previous studies have shown that the sensitivity of blood culture for typhoid diagnosis is on average
59% (95% CI: 54%-64%) but increases by 3% for each additional mL of blood drawn, and decreases by 34% with antibiotic
use in the past 2 weeks.12 Thus, each individual who tested negative for typhoid had a probability 1−wi,v(i),u(i) of being a
false negative and thus a true case of typhoid fever, where wi,v(i),u(i) is the blood culture sensitivity for individual i, v(i) is
the volume of blood collected from individual i, and u(i) = 1 if individual i reported prior antibiotic use in the previous
2 weeks and u(i) = 0 otherwise. Blood culture sensitivity is defined as
wi,v(i),u(i) = (e−0.73+0.03v(i) ) ∗ (1 − 0.34u(i)). (3)
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The use or non-use of antibiotics created a bimodal distribution for the sensitivity based on the observed
individual-level data calculated using Equation (3) (Figure S2). Thus, we chose to model the distribution of sensitivity
among the full population using a normal mixture model with a separate mean and SD for the distribution of blood
culture sensitivity with and without the use of antibiotics, varied over blood culture volume. This mixture model is
denoted
𝜙Sa,c ∣ Ua,c ∼ N(mu,a,c, du,a,c),
Ua,c ∼ Bernoulli(ra,c), (4)
where 𝜙Sa,c is the blood culture sensitivity adjustment from Equation (2), ra,c is the proportion of individuals who took
antibiotics in the past 2 weeks, and mu,a,c and du,a,c represent the mean and SD of the distribution of blood culture sensi-
tivity after adjusting for blood culture volume among those who did (U = 1) and did not (U = 0) take antibiotics (from
the distribution created using Equation 3), again estimated separately for each age category and site.
2.2.2 Adjustment for the probability of receiving a blood culture test (𝜙Ba,c)
The probability of receiving a blood culture test was estimated differently for Malawi vs Nepal and Bangladesh due to
data availability and differences in the primary reasons why individuals were not tested. In Malawi, the main reason
why individuals meeting the fever criteria for enrollment did not receive a blood culture test was due to limited capacity
and long waiting times at the primary health facility. Individuals often arrived at the clinic early in the morning for
clinical review. Once they had seen the government clinician, they were referred for study enrollment and blood-culture
collection. If there was a delay in enrollment activities, individuals often left prior to blood cultures being collected. Thus,
we assumed that data for those who did not receive a blood culture test were missing completely at random. We used the
passive surveillance screening data to estimate the probability of receiving a blood culture test in Malawi, and assumed






where gBa,1 was the number of eligible patients enrolled and j
B
a,1 was the number of eligible patients who were not
enrolled.
In Nepal and Bangladesh, the primary reason febrile individuals did not receive a blood culture test likely depended
on factors associated with their probability of testing positive (eg, age, number of days of fever, and clinical suspicion of
the disease); furthermore, screening data for the passive surveillance were not available. Instead, we relied on published
estimates of the relative risk of typhoid fever among those who did not have blood taken for culture and screening data
from the Typhoid Vaccine Acceleration Consortium (TyVAC).19 As part of TyVAC, typhoid conjugate vaccine trials are
being conducted in the same populations as STRATAA utilizing the same passive surveillance facilities. Baseline infor-
mation on eligible patients presenting to fever surveillance facilities was recorded both for those who did and did not have
blood drawn for culture. Based on the analysis of these data in the TyVAC population in Nepal, the relative risk of blood
culture positivity (RS) was 1.87 times higher (95% CI: 0.9-3.9) among those who received a blood culture test compared
to those who did not.10 Thus, the overall probability of receiving a blood culture test, after taking into account variations
in the risk of typhoid fever among those who are and are not tested, is
𝜙Ba,c = 1 −
(1 − ka,c)
RS
for c ∈ {2, 3}, (5b)
where ka,c is the probability of receiving a blood culture test prior to adjusting for the relative risk of blood cul-
ture positivity. Prior to adjusting for the relative risk, the probability of receiving a blood culture test was assumed
to follow a beta distribution, ka,c ∼ Beta(gBa,c, jBa,c), where gBa,c was the number of eligible patients in age category a
in country c who were enrolled and jBa,c was the number of eligible patients who were not enrolled during TyVAC
(for c = 2 or 3). While the previous analysis focused only on Nepal, we used the same adjustment for the rela-
tive risk of blood culture positivity in Bangladesh, since the reasons for having or not having blood drawn were
similar.
PHILLIPS et al. 9
2.2.3 Adjustment for healthcare-seeking behavior (𝜙Ha,c)
Previous multiplier methods assume that reported healthcare-seeking for a fever is the same as that for typhoid fever;
however, this is not necessarily the case. Individuals with typhoid fever may be more or less likely to seek healthcare. In
preliminary analyses, we found no difference in reported healthcare seeking by severity of a person’s reported fever, but
other factors may explain differential healthcare seeking among those with typhoid fever vs fever due to other causes. To
correct for this difference, we measured the probability of seeking care for a fever adjusted for a specified typhoid risk
factor to estimate the probability of seeking care for typhoid fever (Figure S1), as described below.
For this phase of reporting, we assumed that everyone in the population either had or did not have a typhoid risk
factor, identified from the literature. For each site, we used a different risk factor, based on studies carried out in that
specific site and variables for which data was collected as part of STRATAA. The risk factor identified in Malawi was soap
available after defecation20; in Nepal, it was unshared toilets,21 and in Bangladesh it was boiled drinking water.22
In Malawi, the odds ratio for having typhoid fever was 2.0 (95% CI: 1.3-2.5) comparing those who did not use soap after
defecation to those who did.20 In Nepal, the odds ratio for having typhoid fever was 5.7 (2.3-14.4) comparing those who
used a household latrine to those who shared a community latrine.21 In Bangladesh, the odds ratio for having typhoid was
7.6 (2.2-26.5) comparing those who did not boil drinking water to those who did.22 Since the overall prevalence of typhoid
in the population is low, we used these odds ratio estimates from the literature to approximate relative risks for typhoid.
We used the same relative risk estimates for all age groups. All other values for the healthcare-seeking adjustment were
estimated separately by age and site, as noted below.
We can calculate the marginal probability of seeking care for a fever among those with typhoid fever (alternatively, the
incidence of typhoid after adjusting for blood culture sensitivity and the probability of receiving a blood culture test) as:
𝜆
S,B
a,c = 𝜆0,a,c(h1,a,cRTF,cpa,c + h0,a,c(1 − pa,c)), (6)
where pa,c is the probability of having the risk factor for typhoid fever among individuals in age group a in site c, 𝜆0,a,c
is the incidence of typhoid fever among those without the risk factor, RTF,c is the relative risk for typhoid among those
with the risk factor (and hence RTF,c𝜆0,a,c is the incidence among those with the risk factor), and h1,a,c and h0,a,c are the
probability of self-reported healthcare seeking for a fever among those with and without the risk factor, respectively.
We can also estimate the overall adjusted incidence of typhoid as the weighted average of the population-based
typhoid fever incidence (after adjusting for blood culture sensitivity, the probability of receiving a blood culture test, and
healthcare-seeking) among those with or without the typhoid fever risk factor:
𝜆adjusted,a,c = RTF,c𝜆0,a,cpa,c + 𝜆0,a,c,(1 − pa,c). (7)








h1,a,cRTF,cpa,c + h0,a,c(1 − pa,c)
RTF,cpa,c + (1 − pa,c)
. (8)
The numbers of individuals with the risk factor and who sought healthcare for a fever were observed directly in a
sample of the population in the HUS. We assumed that the probabilities for the occurrence of these numbers (p, h0, h1)
followed an underlying beta distribution based on the observed values (Table 1).
2.2.4 Model validation and sensitivity analyses
The final adjusted incidence of symptomatic typhoid fever should be less than or equal to the seroincidence of typhoid
infections captured in the serosurveillance data. In this study, seroconversion to typhoid was defined as a ≥2-fold rise
in anti-Vi IgG titre between the first and second sample drawn and an absolute titre ≥50 EU/mL at the second time
point. The seroincidence was estimated as the quotient of the number of people who seroconverted between the first
and second blood sample and person-time in years (the number of people sampled multiplied by the mean time between
serological samples in age group a in country c). Since seroincidence includes asymptomatic as well as symptomatic cases,
10 PHILLIPS et al.
it is expected to be higher than the adjusted (symptomatic) incidence. As a result, the final adjusted incidence estimates
should not exceed the upper bound of the estimated seroincidence rates.
To ensure the model was correctly formulated, we simulated data with known probabilities and incidence rates and
compared model estimates to the true values used to generate the data. We simulated high and low values for all of the
parameters estimated in the model, starting with a “true” typhoid fever incidence of 1000 infections per 100 000 pyo.
We began by assuming there were 1250 cases of typhoid fever among 25 000 individuals with a typhoid fever risk factor
(Xi = 1) and 750 cases among 75 000 individuals without the risk factor (Xi = 0) over 2 years of surveillance, such that
RTF = 5. We then sampled from independent Bernoulli random variables, Hi ∼ Bernoulli(hXi ), Bi ∼ Bernoulli(bTFi), and
Ui ∼ Bernoulli(u), for the probability of seeking healthcare (H), the probability of having blood drawn for culturing (B),
and the probability of antibiotic usage (U). We considered high and low values for each probability, which also varied
depending on the risk-factor and typhoid fever status of individual i for h and b, respectively:
hXi=1 =
{
0.1 for low scenario,
0.5 for high scenario,
hXi=0 =
{
0.2 for low scenario,
0.7 for high scenario,
bTFi=1 =
{
0.68 for low scenario,
0.95 for high scenario,
bTFi=0 =
{
0.4 for low scenario,
0.9 for high scenario,
u =
{
0.2 for low scenario,
0.8 for high scenario.
Among individuals with TFi = 1 and antibiotic usage Ui, the probability of testing positive for typhoid fever (ie, test
sensitivity) was Si ∼ Bernoulli(sUi), where
sUi=1 =
{
0.4 for low scenario,
0.5 for high scenario,
sUi=0 =
{
0.6 for low scenario,
0.75 for high scenario.
Under both scenarios, the mean test sensitivity was∼55%. We assumed perfect test specificity, such that si = 0 if TFi = 0.
The incidence of fever due to other causes was assumed to be 5% per year; we did not allow for multiple episodes of fever
over the 2-year period, such that
Fother,i ∼ Bernoulli(0.10).
Moreover, we assumed that the incidence of fever due to any cause was
Fi = max(TFi,Fother,i),
that is, all individuals could have at most one episode of fever, either due to typhoid fever or another cause. We then
generated vectors for whether or not individuals who sought healthcare (HC), had blood drawn for culturing (BC), and
tested positive for typhoid fever (Y) as:
HCi = Fi ∗ Hi,
BCi =
{




BCi ∗ Pi if BCi = 1,
NA otherwise.
We simulated four scenarios using these probabilities: (1) low probability of seeking care, high probability of being
tested, and low prior antibiotic usage; (2) low probability of seeking care, high probability of being tested, and high antibi-
otic usage; (3) high probability of seeking care, low probability of being tested, and low prior antibiotic usage; and (4)
high probability of seeking care, low probability of being tested, and high prior antibiotic usage.
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To evaluate whether the final estimates were sensitive to the number of individuals sampled in the HUS, we compared
estimates for models that sampled approximately the same number of individuals in each age category as the HUS (735)
to models that sampled more individuals (1000 and 2000 individuals).
We additionally compared the adjusted incidence estimates from our model to those from a simpler approach that
assumed there was no variation in blood culture sensitivity due to prior antibiotic use (ie, we used a normal distribution
for 𝜙Sa,c instead of a normal mixture model) and no variation in typhoid incidence among those who were or were not
tested (ie, using the simpler approach to estimate 𝜙Ba,c given in Equation 5a) and those who did or did not seek care (ie,
assuming 𝜙Ha,c is equal to the probability of seeking care for fever). This simpler approach is more commonly used in
multiplier methods for adjustments; however, this approach often faces criticism since it inherently assumes that data are
missing completely at random and that reported healthcare-seeking behavior for a fever is the same as that for typhoid
fever.
2.2.5 Model fitting
To estimate the posterior distributions of the adjusted incidence rates, we collected 100 000 posterior samples from the
adjustment factors described above following a burn-in period of 10 000 iterations prior to convergence. Convergence
was assessed using the Gelman-Rubin diagnostic23 for individual parameters. To ensure the model validation was done
without knowledge of the true values, one person simulated the data and another person fit the model to the simulated
data. Code for generating simulated data was written in MATLAB version 9.3.0.24 All other analyses were performed
using JAGS version 4.3.0 25 in R version 3.4.0.26 Model code, including code for generating the simulated data, is provided
at https://github.com/mailephillips/adjusted-typhoid-incidence.27
3 RESULTS
The magnitude of the adjustment factors used to estimate the incidence of typhoid fever varied among the three sites
(Table 2). In Nepal and Bangladesh, the probability of seeking healthcare was low (𝜙Hc=2 = 0.15, 95% credible interval (CrI):
0.09-0.22; and 𝜙Hc=3 = 0.27, 95% CrI: 0.22-0.33, for all ages) and thus contributed the most to the adjustments, while the
probability of receiving a blood culture test when eligible was high (𝜙Bc=2 = 0.84, 95% CrI: 0.67-0.92; and 𝜙
B
c=3 = 0.96, 95%
CrI: 0.92-0.98) and contributed the least to adjustments. However, in Malawi, the probability of seeking healthcare was rel-
atively high (𝜙Hc=1 = 0.71, 95% CrI: 0.64-0.77), while the probability of receiving a blood culture test was low (𝜙
B
c=1 = 0.35,
95% CrI: 0.34-0.36). Blood culture sensitivity was fairly consistent across sites, with median estimates of 𝜙Sc = 0.54 to 0.55.
The different adjustment factors also varied by age. Blood culture sensitivity was slightly higher in older age groups
compared to younger age groups (median estimates of individuals >14 years, 𝜙Sa∈(4,5) = 0.56−0.58; compared to children
≤14 years,𝜙Sa∈(1,2,3) = 0.53−0.54). While there was no consistent pattern in prior antibiotic use by age, the amount of blood
drawn for a blood culture test generally increased with age. As a result, blood culture sensitivity slightly increased with
age. Had we not adjusted for blood culture volume or prior antibiotic use, the estimate for blood culture sensitivity would
have been higher for all ages and countries (Figure S5, in blue).
The probability of receiving a blood culture test had different patterns across age groups depending on the country.
In Malawi, the probability of receiving a blood culture test decreased with age (𝜙B1,1 = 0.40, 95% CrI: 0.38−0.41 for chil-
dren <5 years vs 𝜙B5,1 = 0.20, 95% CrI: 0.17−0.23 for adults 30+ years), while in Nepal and Bangladesh, the probability
increased (𝜙B1,2 = 0.81, 95% CrI: 0.61−0.91 and 𝜙
B
1,3 = 0.94, 95% CrI: 0.87−0.97 for children <5 years vs 𝜙
B
5,2 = 0.91, 95%
CrI: 0.71−0.98 and 𝜙B5,3 = 0.98, 95% CrI: 0.96−0.99 for adults 30+ years). If we had used a simpler approach (not adjust-
ing for the variation in the risk of typhoid fever among those who were and were not tested) to adjust for the probability
of receiving a blood culture test in Nepal and Bangladesh, we would have underestimated the probabilities and thus
overestimated the contribution of this adjustment (Figure S5). In Nepal, in particular, the simpler approach would have
substantially underestimated the probability of receiving a blood culture test among younger age groups. In Bangladesh,
the unadjusted proportion of individuals receiving a blood culture test was already close to one, so the adjusted value did
not increase the estimate considerably.
The probability of seeking healthcare did not have a consistent pattern across age groups, likely due to the different
components contributing to the final estimate. Malawi overall had the highest rates of healthcare seeking, with the lowest
rates among children under 5 and the highest rates among children 5 to 14 (Table 2). Nepal had the lowest rates of
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T A B L E 3 Estimated adjustment factors from final models
Age (years) Malawi Nepal Bangladesh
0 to 4 7.6 (4.8-11.6) 10.7 (4.3-26.8) 6.3 (4.2-10.2)
5 to 9 5.9 (4.1-8.3) 19.7 (9.0-54.9) 5.8 (4.1-8.6)
10 to 14 6.9 (4.3-10.4) 19.6 (8.6-55.2) 5.8 (3.9-8.9)
15 to 29 11.4 (6.9-18.0) 15.8 (7.4-42.4) 9.8 (6.2-16.7)
30+ 12.0 (6.0-21.7) 15.0 (4.6-48.8) 9.7 (5.5-17.9)
All ages 7.7 (6.0-12.4) 14.4 (9.3-24.9) 7.0 (5.6-9.2)
Note: The ratio of the median estimate (95% credible interval) of
adjusted-to-observed incidence rates is shown for each country and age category.
healthcare seeking overall, with slightly higher rates among children under 5. Bangladesh also had low healthcare seeking
rates, with the lowest rates among adults 15+ years of age (Table 2). In Malawi and Bangladesh, the proportion of those
with the relevant typhoid risk factor did not differ by age group (Table S2). Healthcare seeking for a fever was higher among
those with the typhoid risk factor in Malawi, but lower among those with the risk factor in Bangladesh and Nepal. When
compared to the simpler approach to estimate the probability of healthcare seeking (using the unadjusted proportion of
those who sought care for fever), the estimates were similar but slightly higher in most age groups in Malawi but slightly
lower in Nepal and Bangladesh (Figure S5).
The magnitude of the overall adjustment to estimate typhoid fever incidence (𝜆adjusted,a,c∕𝜆observed,a,c = (𝜙Sa,c𝜙Ba,c𝜙Ha,c)−1)
varied between countries and age groups. Nepal had the highest adjustment factors in every age group, with an overall
adjustment factor of 14.4 (95% CrI: 9.3–24.9). Malawi and Bangladesh were similar, with adjustment factors of 7.7 (95%
CrI: 6.0–12.4) and 7.0 (95% CrI: 5.6–9.2), respectively (Table 3). The highest adjustment factor was for the 5 to 9-year age
group in Nepal (19.7, 95% CrI: 9.0-54.9), while the lowest was for the 5 to 9- and 10 to 14-year age groups in Bangladesh
(5.8, 95% CrI: 4.1–8.6; and 5.8, 95% CrI: 3.9–8.9, respectively).
Most of the final adjusted incidence estimates fell below the upper bound of the estimated seroincidence of typhoid
infection (Table 4). In Malawi and Bangladesh, all of the upper bounds of the estimates were well within or below the
upper bounds of the seroincidence rate confidence intervals. In Nepal among children aged 5 to 9 years, the upper bound
of the adjusted incidence rate exceeded that of the estimated seroincidence; however, the confidence/credible intervals
overlapped. Similarly, children 10 to 14 years of age in Bangladesh had a higher median adjusted incidence rate than
seroincidence (which was the lowest across all age groups and sites), but the upper bound of the adjusted incidence
credible interval was still lower than the upper bound of the confidence interval for seroincidence.
When we evaluated the model against simulated data, the full model was able to reliably estimate both the “true” inci-
dence of typhoid fever and the probabilities used to generate the simulated data for a range of values, while the simpler
approach over- or under-estimated the true incidence in some scenarios (Figures 2 and S3). Estimates of blood culture
sensitivity were similar to the true value, but incorporated additional uncertainty compared to the simpler approach, con-
sistent with the different sensitivity of blood culture in those who reported prior antibiotic use compared to those that did
not (Figure S3). The probability of receiving a blood culture test contributed most to the difference in accuracy between
the two approaches. In every scenario, the full model reliably estimated the true value, while the simpler approach under-
estimated the true value (Figure S3). The adjustment for healthcare seeking in the full model again consistently captured
the true value across levels of the probability as compared to the simpler approach, which generally had a narrower 95%
CrI that did not always contain the true value (Figure S3). As expected, in both models, the uncertainty in the probability
of seeking healthcare decreased as the sampling fraction for the hypothetical HUS increased. As a result, the 95% CrIs in
the overall incidence estimates also narrowed as the sampling fraction increased (Figure 2).
4 DISCUSSION
In order to make informed decisions regarding typhoid control and prevention, it is important to have accurate estimates
of population-based typhoid fever incidence. Unreliable reports, inconsistent healthcare utilization, inconsistent clinical
diagnoses, suboptimal diagnostic tests, and scarcity of accurate or full data contribute to difficulties in calculating the
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F I G U R E 2 Estimated typhoid incidence based on simulated data: Full model vs simplified approach. The typhoid incidence per
100 000 person-years of observation was estimated from simulated data based on a true incidence of 1000 typhoid infections per 100 000
person-years (dashed horizontal black line). Data were simulated for low and high probabilities of seeking healthcare, receiving a blood
culture diagnostic test, and antibiotic use. Scenarios were as follows: (1) low probability of seeking care, high probability of being tested, and
low prior antibiotic usage; (2) low probability of seeking care, high probability of being tested, and high prior antibiotic usage; (3) high
probability of seeking care, high probability of being tested, and low prior antibiotic usage; and (4) high probability of seeking care, high
probability of being tested, and high prior antibiotic usage. Each simulation was performed sampling 735; 1000; and 2000 individuals from
the population for the hypothetical healthcare utilization survey. Estimated “true” values are shown for models that did (red) and did not
(blue) account for variation in blood culture sensitivity and variation in typhoid incidence among those who did or did not seek care and
were or were not tested [Colour figure can be viewed at wileyonlinelibrary.com]
population-based incidence of typhoid fever. We developed a new methodology within the Bayesian setting to estimate
population-based incidence in a context where cases often go undetected and under-reported. Through this approach, we
were able to calculate the adjustment factors that can be applied to estimate the “true” incidence of typhoid fever in the
STRATAA surveillance sites. These estimates suggested that the adjusted incidence of typhoid fever in Malawi, Nepal,
and Bangladesh is 7- to 14-fold higher than the reported blood-culture-confirmed numbers.
It is commonly accepted that cases of typhoid fever go unrecognized at each phase of the reporting process, but the
degree to which each step contributes to the underestimation of and uncertainty in the population-based incidence is
often not fully quantified. Each of the three intervening processes contributed differently to the underestimation in each
country and age group. The probability of seeking healthcare was responsible for the largest portion of underestimation
in Nepal and Bangladesh, while the probability of receiving a blood culture test was the biggest factor in Malawi. These
results reflect differences in the healthcare systems and fever surveillance processes at the different sites. In Nepal and
Bangladesh, antibiotics are widely available and individuals tend to seek care first at a pharmacy instead of a healthcare
facility.28 In Nepal, a considerable proportion of people with fever neither seek healthcare nor visit a pharmacy possibly
due to lack of funds. In Malawi, healthcare seeking is high, but the resources at healthcare facilities are limited. As a
result, many people report to healthcare facilities with a fever, receive antibiotics, but do not remain in the facility long
enough to receive an additional blood culture test due to prolonged wait times.
Other studies use different approaches to estimate the true incidence of typhoid fever. In many cases, studies simply
double the reported cases to account for blood culture sensitivity.29 Numerous studies make use of a simple multiplier
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method,30-33 which often do not accurately reflect the uncertainty associated with the reporting process. Previous studies
have not attempted to integrate data sources to account for potential differences between the observed healthcare seek-
ing and testing probabilities for fever vs the corresponding unobserved probabilities specific to typhoid fever, which our
analysis suggests can impact the final adjustment factors. Our approach can be used to estimate typhoid fever incidence
in other study populations. Moreover, some of the issues we encountered (eg, under-detection due to poor test sensitivity
that varies depending patient characteristics, preferential testing of individuals more likely to have the disease of interest,
and potential differences in healthcare seeking for those who have the syndrome vs disease of interest) are common to
other diseases as well.
By utilizing a Bayesian approach, we were able to measure the contribution to underestimation at each phase of the
reporting process while also properly quantifying the uncertainty for each of our estimates. When comparing our model
to simulated data, we showed that having more data available (due to higher probabilities of seeking care and receiving a
blood culture test) reduced uncertainty in the estimates. Furthermore, we showed that if more people had been sampled
in the HUS, uncertainty would also have been reduced.
Our analysis and approach had some limitations. We assumed that healthcare-seeking behavior for fever in house-
holds without children is the same as households with children, because the HUS only sampled households with children.
Less than a third of households did not have children and were not included in this survey across sites. Studies suggest
that households with children are more likely to seek healthcare,34 which means that if our estimates are biased, the
adjusted incidence estimates are likely conservative. We also were not able to differentiate between febrile illnesses at dif-
ferent parts of the reporting process. We addressed this issue by adjusting for possible differences in healthcare seeking
among those with typhoid fever compared to other febrile etiologies using weighted averages based on known risk fac-
tors for typhoid fever, but other factors may also lead to differences in healthcare seeking for fever vs for typhoid fever. By
comparing our adjusted incidence estimates to estimates of seroincidence, we are able to provide some assurance that the
adjusted incidence is within the range of plausible values. However, methods and immunological markers for estimat-
ing the seroincidence of typhoid fever are not well established, and the cut-off we used (a ≥2-fold and absolute value of
≥50 EU/mL in anti-Vi IgG) may not be a reliable indicator of acute typhoid infection across all individuals and immuno-
logical backgrounds. Another limitation of the approach is that it can very labor-intensive and time-consuming to collect
the necessary data.
Calculation of incidence based on data from passive surveillance of blood-culture-confirmed typhoid fever results in
considerable underestimation of the true incidence of typhoid fever in the population. Our model provides an approach
for estimating typhoid fever incidence while accounting for different sources of information from the reporting process.
Typhoid fever remains a major cause of morbidity and mortality in developing countries, so control and prevention are
needed. To effectively prioritize, implement and evaluate interventions, estimates of the number of cases should accu-
rately reflect the uncertainty in the reporting process. This analysis provides a platform that can be updated with new or
additional data as they become available and can be adapted to other contexts. This model framework could also be used
to adjust for underreporting in other diseases.
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